Search

Your search keyword '"Hou, M.-F."' showing total 146 results

Search Constraints

Start Over You searched for: Author "Hou, M.-F." Remove constraint Author: "Hou, M.-F."
146 results on '"Hou, M.-F."'

Search Results

2. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

3. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

5. 142P Effectiveness and safety of pegylated liposomal doxorubicin- cyclophosphamide vs. epirubicin-cyclophosphamide as adjuvant chemotherapy for stage I and II HER2-negative breast cancer: An interim analysis of phase II randomized trial

7. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

10. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element.

11. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

12. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

14. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

15. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.

16. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

17. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

18. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

19. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

21. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

23. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

24. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

26. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

27. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

28. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

29. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

30. LBA1 First-line ribociclib + letrozole in postmenopausal Asian women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2

31. Comparison of 6q25 Breast Cancer Hits from Asian and\ud European Genome Wide Association Studies in the\ud Breast Cancer Association Consortium (BCAC)

32. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

33. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

34. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

35. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

36. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

37. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

38. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

39. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

43. Comparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association consortium (BCAC)

44. Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

45. 11q13 is a susceptibility locus for hormone receptor positive breast cancer

46. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor- positive, lower grade breast cancer

47. LBA1 First-line ribociclib 1 letrozole in postmenopausal Asian women with hormone receptor-positive (HR1), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): A subgroup analysis from MONALEESA-2

48. Distant metastasis in triple-negative breast cancer

Catalog

Books, media, physical & digital resources